News Daily News Women With Prior SCAD Not Always at Risk of Recurrence in Pregnancy Caitlin E. Cox September 25, 2020
News Daily News Among US Women, Awareness of CVD’s Threat Has Declined L.A. McKeown September 25, 2020
News Daily News VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks Michael O'Riordan September 24, 2020
News Daily News Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD Michael O'Riordan September 22, 2020
News Daily News Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care Shelley Wood September 22, 2020
News Daily News CABG Loses Survival Advantage in Women at 10 Years: SYNTAXES Yael L. Maxwell August 20, 2020
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020
News Conference News SCCT 2020 For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change Yael L. Maxwell July 28, 2020
News Conference News SCCT 2020 Biggest Barriers to Cardiac CT? Old Myths, Fair Payment, and De-adoption Yael L. Maxwell July 22, 2020
News Conference News SCCT 2020 ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT Yael L. Maxwell July 20, 2020
News Daily News Smoking Still Common, Tied to Higher Mortality in Young MI Patients Yael L. Maxwell July 09, 2020
News Daily News TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data Michael O'Riordan June 01, 2020
News Daily News US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable Shelley Wood May 29, 2020
News Daily News US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors L.A. McKeown May 28, 2020
News Daily News Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans Michael O'Riordan May 15, 2020
News Daily News FOURIER Surveys Reassure About Cognitive Safety of Evolocumab Todd Neale May 06, 2020
News Daily News COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk Michael O'Riordan May 05, 2020
News Daily News Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES Michael O'Riordan May 04, 2020